Tetherex Pharmaceuticals, Inc. is a privately held, clinical stage biopharmaceutical company focused on development of selectin inhibitor therapeutics for the treatment of a broad range of inflammatory diseases and single-cycle adenovirus vaccines for multiple infectious diseases and cancer indications.
View Top Employees from Tetherex Pharmaceuticals CorporationWebsite | http://www.tetherex.com |
Revenue | $5 million |
Employees | 1 (1 on RocketReach) |
Founded | 2014 |
Address | 840 Research Pkwy, Ste 516, Oklahoma City, Oklahoma 73104, US |
Phone | (405) 319-8195 |
Fax | (405) 319-8197 |
Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Drug Discovery, Health Care, Pharmaceutical |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Tetherex Pharmaceuticals Corporation employee's phone or email?
The Tetherex Pharmaceuticals Corporation annual revenue was $5 million in 2024.
1 people are employed at Tetherex Pharmaceuticals Corporation.
Tetherex Pharmaceuticals Corporation is based in Oklahoma City, Oklahoma.
The NAICS codes for Tetherex Pharmaceuticals Corporation are [325, 3254, 32, 32541].
The SIC codes for Tetherex Pharmaceuticals Corporation are [283, 28].